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This study investigated the effect of post-exercise sodium bicarbonate (NaHCO3) ingestion on acid-2 
base balance recovery and time-to-exhaustion (TTE) running performance. Eleven male runners 3 
(stature, 1.80 ± 0.05 m; body mass, 74.4 ± 6.5 kg; maximal oxygen consumption, 51.7 ± 5.4 ml.kg-4 
1.min-1) participated in this randomised, single-blind, counterbalanced and crossover design study. 5 
Maximal running velocity (v-VO2max) was identified from a graded exercise test. During experimental 6 
trials, participants repeated 100% v-VO2max TTE protocols (TTE1, TTE2) separated by 40 min 7 
following the ingestion of either 0.3 g.kg-1 BM NaHCO3 (SB) or 0.03 g.kg-1 BM sodium chloride (PLA) 8 
at the start of TTE1 recovery. Acid-base balance (blood pH and bicarbonate, HCO3-) data were studied 9 
at baseline, post-TTE1, after 35 min recovery and post-TTE2. Blood pH and [HCO3-] were unchanged 10 
at 35 min recovery (p > 0.05), but [HCO3-] was elevated post-TTE2 for SB vs. PLA (+2.6 mmol.l-1; p 11 
= 0.005; g = 0.99). No significant differences were observed for TTE2 performance (p > 0.05), although 12 
a moderate effect size was present for SB vs. PLA (+14.3 s; g = 0.56). Post-exercise NaHCO3 ingestion 13 
is not an effective strategy for accelerating the restoration of acid-base balance or improving subsequent 14 
TTE performance when limited recovery is available. 15 
 16 
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 18 
BULLET POINTS 19 
 Post-exercise sodium bicarbonate ingestion did not accelerate the restoration of blood pH or 20 
bicarbonate after 35 minutes 21 
 Performance enhancing effects of sodium bicarbonate ingestion may display a high degree of 22 
inter-individual variation 23 
 Small-to-moderate changes in performance were likely due to greater up-regulation of 24 
glycolytic activation during exercise 25 
 26 
  27 
 
INTRODUCTION 28 
Repeated high-intensity training sessions and events require athletes to be able to maximally exert 29 
themselves with often only limited recovery between exercise bouts (Barnett, 2006). The considerable 30 
reliance on the ATP-PCr and glycolytic energetic systems results in the rapid accumulation of 31 
biochemical metabolites such as inorganic phosphate, hydrogen cations (H+) and lactate within 32 
contracting muscle (Allen et al., 2008). Naturally occurring extracellular buffering mechanisms (e.g., 33 
blood bicarbonate, HCO3-) act to remove these H+ from the muscle cytosol (Sahlin, 2014), however the 34 
production of H+ overwhelms the rate of neutralisation reactions, contributing towards reduced 35 
intramuscular pH (Allen et al., 2008). These metabolically derived disruptions to acid-base balance (i.e., 36 
equilibrium between acidity and alkalinity of bodily fluids) have been linked to greater peripheral 37 
fatigue via the inhibition of glycolytic flux (Messonnier et al., 2007), disruption of calcium ion cross-38 
bridge formation (Fitts, 2016) and reduced muscle excitability (Sostaric et al., 2006). Extracellular 39 
buffering aids such as sodium bicarbonate (NaHCO3) that protect against disturbances to acid-base 40 
balance homeostasis could therefore prove beneficial to athletes performing repeated bouts of maximal 41 
effort that are likely to exacerbate metabolic perturbation.  42 
Pre-exercise ingestion of 0.3 g.kg-1 BM NaHCO3 enhances extracellular buffering capacity by 43 
eliciting a metabolic alkalosis (i.e., increased blood [HCO3-] of ~5-7 mmol.l-1) that allows for greater 44 
H+ efflux from the muscle (Messonnier et al., 2007), which may result in moderate ergogenic benefits 45 
during high-intensity exercise (see review, Hadzic et al., 2019). This nutritional strategy also accelerates 46 
the restoration of acid-base balance homeostasis within ~40 mins (Pruscino et al., 2008; Gough et al., 47 
2019a), but it is unclear whether the heightened HCO3- buffering response extends to subsequent athletic 48 
performance (i.e., for athletes competing in multiple exercise events). Authors investigating the effect 49 
of pre-exercise NaHCO3 ingestion on repeated bout performance reported minimal ergogenic benefits 50 
during wingate protocols (3x30 s; 15 min recovery) and swimming time-trials (2x200 m; 30 min 51 
recovery) (Zabala et al., 2011; Pruscino et al., 2008). It is expected that pre-exercise ingestion resulted 52 
in the enhanced HCO3- buffering capacity being completely utilised within the preliminary bout (i.e., 53 
from protecting against severe acid-base balance disturbances), which would explain blunted 54 
performance benefits during subsequent exercise bouts.  55 
 
One relatively novel strategy that accounts for this concern is post-exercise NaHCO3 ingestion, 56 
ensuring that a greater alkalotic response is present during recovery and subsequent exercise bouts. 57 
Previous studies have demonstrated that NaHCO3 ingested either immediately post-exercise or 30 min 58 
after a fatiguing bout elevates blood pH (~0.10 units) and [HCO3-] (~7-8 mmol.l-1) following a 75-90 59 
min recovery period (Gough et al., 2017; Gough et al., 2019), which subsequently improved time-to-60 
exhaustion (TTE) running (+70 s; p = 0.084) and cycling (+35 s; p = 0.007). Since the authors opted 61 
for relatively long recovery windows, it was noted that blood pH and [HCO3-] had not only recovered 62 
prior to subsequent exercise, but instead reflected a state of pre-exercise metabolic alkalosis following 63 
NaHCO3 ingestion (~7.48 units, ~32 mmol.l-1). Consequently, the ergogenic responses reported may 64 
have represented the well-established pre-exercise application of NaHCO3 ingestion. It is therefore 65 
considered more appropriate to investigate the potential ergogenic effect of post-exercise NaHCO3 66 
when ingested during a shorter recovery period between two exercise bouts.  67 
Performance enhancing effects following NaHCO3 are not exclusively attributed to substantial 68 
changes in blood pH and [HCO3-] response (Siegler et al., 2016). This alkalotic state may also increase 69 
glycolytic activation by preventing the allosteric inhibition of enzymes such as glycogen phosphorlyase 70 
and phosphofructokinase (Messonnier et al., 2007). Pre-exercise NaHCO3 ingestion has been 71 
demonstrated to augment glycolytic flux during high-intensity exercise protocols (da Silva et al., 2019; 72 
Gurton et al., 2020). The effect of a post-exercise NaHCO3 supplementation strategy on energy system 73 
contribution during subsequent exercise remains underexplored, although authors have suggested 74 
enhanced glycolytic flux via elevated post-exercise blood lactate (BLa-) concentration after a 75-90 min 75 
recovery (Gough et al., 2017b; Gough et al., 2019b). It is conceivable that some athletes will have less 76 
time to recover between high-intensity exercise bouts, therefore research should examine whether 77 
NaHCO3 ingested at the start of a shorter recovery period is still able to alter energy demand and 78 
contribution from the glycolytic and oxidative systems. 79 
From an applied perspective, athletes might be particularly attracted to nutritional strategies 80 
that maximise ergogenic benefits during a second competition bout (i.e., track running/cycling, heat 81 
then final; regional tennis, first and second round match). In these instances, ingestion of NaHCO3 82 
during a recovery period may prove more beneficial to subsequent performance. The purpose of this 83 
 
study was to investigate the effect of post-exercise NaHCO3 ingestion on the recovery of acid-base 84 
balance (blood pH, [HCO3-], base excess) within 35 mins and subsequent TTE running performance. 85 
 86 
MATERIALS AND METHODS 87 
Experimental approach to the problem 88 
A block randomised, across subjects single-blind, placebo-controlled, counterbalanced, crossover 89 
experimental design was implemented for this study. Experimental trial order was allocated by the 90 
principal investigator using an online randomised number generator (www.randomization.com) and 91 
blinded from other members of the research team. Participants attended three separate laboratory visits 92 
in a 3-h post-prandial state to perform a graded exercise test and two experimental trials (separated by 93 
5-7 d). All testing was completed at Surrey Human Performance Institute at the same time of day to 94 
minimise the confounding effects of circadian rhythms on exercise performance (Reilly, 1990). The 95 
final speed completed during the graded exercise test was classified as maximal velocity (100% v-96 
VO2max) and used to prescribe TTE speed. During experimental trials, participants repeated 100% v-97 
VO2max TTE protocols separated by 40 mins following the ingestion of either NaHCO3 (SB) or sodium 98 
chloride (NaCl; PLA) at the start of recovery. Vigorous exercise and the consumption of alcohol were 99 
prohibited for 24-h prior to visits. Participants were instructed to record nutritional intake for 72-h prior 100 
to attending the first laboratory visit using food diaries, which were checked by the principal 101 
investigator and returned to participants to replicate before each experimental trial. Online databases 102 
were used by the research team to determine the composition and nutritional content of foods. 103 
 104 
Participants  105 
A priori power calculation (β = 0.8; α = 0.05) using previous partial eta-squared effect size data (ηp
2; 106 
0.6) for post-exercise blood pH recovery (Gough et al., 2017a) revealed that a sample size of 10 would 107 
allow detection of significant changes in blood pH  (G*Power 3, Heinrich Heine, Düsseldorf, Germany). 108 
Eleven recreationally trained runners (stature: 1.80 ± 0.05 m; body mass: 74.4 ± 6.5 kg; age: 31.0 ± 9.7 109 
years; maximal oxygen consumption: 51.7 ± 5.4 ml.kg-1.min-1) were enrolled onto this study from a 110 
local running club according to the CONSORT 2010 guidelines (Figure 1). All participants completed 111 
 
at least 60 min vigorous exercise per week, had no history of hypertension (>140/90 mmHg) or renal 112 
insufficiencies and had not ingested buffering agents within the previous 6 months. All study procedures 113 
were reviewed and approved prior to commencing research by the Faculty of Health and Medical 114 
Sciences ethics committee at the University of Surrey (1366-FHMS-18). Participants gave informed 115 
consent prior to participating in the study. Procedures were conducted in full accordance with the World 116 
Medical Association’s Declaration of Helsinki. 117 
 118 
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 120 
Procedures 121 
On the initial visit, baseline physiological measures were recorded (stature, body mass, blood pressure), 122 
before participants performed a graded exercise test on a treadmill to determine 100% v-VO2max for 123 
TTE protocols. Gaseous exchange was collected using a breath-by-breath metabolic cart (Geratherm 124 
Respiratory, Love Medical, Germany). After a 5 min warm-up at 6 km.h-1 and 1% gradient, the speed 125 
increased by 1 km.h-1 every 1 min until volitional exhaustion was achieved (Price and Halabi, 2005). 126 
This was deemed as the failure to maintain treadmill speed despite strong verbal encouragement. Heart 127 
rate and rating of perceived exertion (RPE) were recorded at the end of each stage and volitional 128 
exhaustion. Data were averaged over the peak 30 s for calculating VO2max (Beltz et al., 2016) and 100% 129 
v-VO2max was classified as the final completed speed during the graded exercise test. 130 
 On arrival to the laboratory during experimental trial visits, participants completed visual 131 
analog scales for gastrointestinal (GI) discomfort (0 mm = “no symptom at all”; 100 mm = “severest 132 
symptom imaginable”) to quantify perceived severity of flatulence, abdominal discomfort (AD), gut 133 
fullness (GF), bowel urgency rating (BUR) and diarrhoea (Gough et al., 2017a; Gurton et al., 2020). 134 
Resting capillary blood samples (95 μl) were collected into end-to-end sodium-heparised capillary tubes 135 
(EKF Diagnostics GmbH, Germany) and analysed for acid-base balance (blood pH, [HCO3-], base 136 
excess) using a handheld analyser (i-STAT, Abbott Point of Care, New Jersey). The i-STAT analyser 137 
demonstrates excellent accuracy and precision for determination of blood pH and [HCO3-] after 138 
maximal exercise (intraclass correlation coefficients, ICC; r = 0.88, 0.86) (Dascombe et al. 2007). 139 
 
Additional 20 μl blood samples were analysed for [BLa-] using an automatic analyser (Biosen C-Line, 140 
EKF Diagnostic GmbH, Germany) that displays excellent precision (coefficient of variation, CV: 141 
<1.5%; EKF Diagnostics, 2017). Participants perceived readiness to exercise (PRE) was measured, 142 
before completing the first running TTE protocol (TTE1) at 100% v-VO2max on the treadmill (1% 143 
gradient). Breath-by-breath expired gaseous exchange and RPE were recorded throughout TTE 144 
protocols. Capillary blood samples and visual analog scales were performed immediately post-TTE1, 145 
before participants consumed either 0.3 g.kg-1 BM NaHCO3 (SB) or 0.03 g.kg-1 BM NaCl (PLA) after 146 
5 min recovery. These doses were chosen to replicate experimental design from previous studies 147 
examining the effect of either pre- or post-exercise NaHCO3 ingestion on recovery (Pruscino et al., 148 
2008; Gough et al., 2017b; Gough et al., 2019b). Experimental beverages were administered single-149 
blind as a chilled solution of 400 ml water and 100 ml orange squash to ensure palatability and taste-150 
matching (Lavender and Bird, 1989). Pilot testing revealed it was not possible to taste-match an 151 
equimolar 0.21 g.kg-1 BM NaCl dose (i.e., equal Na+ content between beverages). Participants 152 
consumed beverages as fast as possible but were allocated a 5 min period if required (i.e., by 10 min 153 
post-TTE1), before completing a supplement belief questionnaire to assess the single-blind design and 154 
whether bias regarding the effect of NaHCO3 was transferred onto participants (Gough et al. 2017a). 155 
Capillary blood samples and visual analogue scales were repeated following 35 min recovery (30 min 156 
post-ingestion). Participants were asked for their PRE and performed the second TTE protocol (TTE2) 157 
at 100% v-VO2max on the treadmill (40 min after TTE1). Additional blood samples were collected post-158 
TTE2, while visual analogue scales were completed post-exercise and for a 24-h post-laboratory phase. 159 
Composite scores for GI discomfort were calculated at each time point from the sum of symptom 160 
severity (i.e., scored out of 500 mm). An overview of experimental procedure is displayed in Figure 2. 161 
 162 
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 164 
Estimated energy system contribution calculations 165 
Absolute energy demand and contribution from the oxidative and glycolytic energetic systems were 166 
estimated during TTE running protocols via non-invasive techniques (Milioni et al., 2017; Brisola et 167 
 
al., 2015). Oxidative phosphorylation (WAER) was calculated by subtracting resting oxygen 168 
consumption (i.e., the average VO2 value during the final 30 s of baseline) from the area under the 169 
oxygen consumption curve for TTE protocols (di Prampero and Ferretti, 1999). Area under the curve 170 
was calculated using the trapezoidal method. This approach provides reliable and valid estimations for 171 
WAER during high-intensity exercise (da Silva et al., 2019; Milioni et al., 2017). Glycolytic (W[LA]) was 172 
calculated from delta blood lactate (ΔBLa-) during TTE protocols, according to the assumption that a 173 
difference of 1 mmol.l-1 of BLa- corresponded to 3 ml.kg-1 BM of O2 (Milioni et al., 2017; Brisola et 174 
al., 2015; Gurton et al., 2020), by using the following equation: W[LA] = ΔBLa- x 3 x body mass (kg). 175 
The caloric quotient of 20.92 kJ was used to convert between absolute energy demand (in L of O2) and 176 
energy contribution (in kJ) for both energetic systems.  177 
 178 
Statistical analysis 179 
Normality and sphericity were assessed using Shapiro-Wilk and Mauchly tests, respectively. Any 180 
violations were corrected via Greenhouse Geisser adjustments. Reproducibility of pre-trial nutritional 181 
intake, TTE1 performance, perceived difficulty to exercise and initial acid-base balance perturbation 182 
were determined from ICC’s and categorised as either poor (r ≤ 0.40), fair (r = 0.40 – 0.59), good (r = 183 
0.60 – 0.74) or excellent (r ≥ 0.74) (Atkinson and Nevill, 1998). Acid-base balance (primary outcome 184 
measure) data were analysed using two-way (treatment x time) repeated measures ANOVA’s, whereby 185 
interaction effects were presented as a p value and effect size (ηp
2) (Olejnik and Algina, 2003). 186 
Significant interactions were explored further by performing one-way repeated measures ANOVA 187 
across treatments at a priori defined time points (i.e., post-TTE2) using the bonferroni correction factor. 188 
The assumption of normal distribution was violated for GI discomfort therefore Friedman’s two-way 189 
ANOVA’s were conducted as non-parametric alternative. Post-hoc Wilcoxon matched pair signed rank 190 
tests were performed when significance was observed (median and Z score reported). Fisher’s exact 191 
test was used to assess the efficacy of the single-blind design. Paired t-tests were conducted on TTE2 192 
performance (secondary outcome measure) and perceived difficulty to exercise. The within-subject CV 193 
for the TTE1 protocol was calculated as 4.9% and used to interpret individual responses for changes in 194 
 
TTE2 performance. Between treatment effect sizes were calculated by dividing mean differences by 195 
pooled SD, before applying Hedges g bias correction (Lakens, 2013). These were interpreted as trivial 196 
(< 0.20), small (0.20 – 0.49), moderate (0.50 – 0.79), or large (≥ 0.80) (Cohen, 1988). Data are presented 197 
as Mean ± SD (unless otherwise stated) and 95% confidence intervals (CI) reported for between 198 
treatment statistical differences. Statistical significance was set at p < 0.05 and data were analysed using 199 
SPSS v26 (SPSS Inc., IBM, USA). 200 
 201 
RESULTS 202 
Pre-trial nutritional intake 203 
Participants demonstrated an excellent degree of repeatability for pre-trial nutritional intake during SB 204 
and PLA trials for daily calories (r = 0.89, p = 0.001), carbohydrate (r = 0.87, p = 0.002), fat (r = 0.83, 205 
p = 0.005) and protein (r = 0.83, p = 0.014).  206 
 207 
Acid-base balance status 208 
Initial acid-base balance perturbation demonstrated an excellent level of reproducibility during SB and 209 
PLA trials for post-TTE1 blood pH (r = 0.94; p < 0.001), [HCO3-] (r = 0.95; p < 0.001), base excess (r 210 
= 0.92; p < 0.001) and [BLa-] (r = 0.93; p < 0.001). Significant two-way interactions (treatment x time) 211 
were observed for [HCO3-] (p = 0.002; ηp
2 = 0.413) and [BLa-] (p = 0.023; ηp
2 = 0.269), but not for blood 212 
pH (p = 0.070; ηp
2 = 0.227) or base excess (p = 0.242; ηp
2 = 0.141). Acid-base balance status was 213 
unchanged at 35 min recovery (p > 0.05). Exploratory analysis on a small sub-set (n = 6) of blood pH 214 
and [HCO3-] data at 40 min recovery (i.e., immediately pre-TTE2; not an a priori defined time point) 215 
revealed a larger magnitude of effect for SB vs. PLA (+0.03 units; +3.9 mmol.l-1). Post-TTE2 [HCO3-] 216 
was significantly elevated for SB vs. PLA (p = 0.005) and displayed a large effect size (+2.6 mmol.l-1; 217 
CI: 1.0, 4.2; g = 0.99). Peak [BLa-] following TTE2 was significantly higher for SB vs. PLA (p = 0.015) 218 
and displayed a large effect size (+1.4 mmol.l-1; CI: 0.3, 2.5; g = 0.82). Mean ± SD values for changes 219 
in acid-base balance status from baseline to post-TTE2 are displayed in Figure 3 (A-D). 220 
 221 
 
[INSERT Figure 3 (A-D) NEAR HERE] 222 
 223 
Time-to-exhaustion running performance 224 
Performance during TTE1 demonstrated an excellent degree of repeatability for SB and PLA trials (r = 225 
0.95; p < 0.005; within-subject CV = 4.9%). No significant differences were observed for TTE2 226 
performance (+14.3 s; p = 0.071), although a moderate effect size was present for SB vs. PLA (+9.7%; 227 
g = 0.56). There was a large degree of individual variability for TTE2 performance, whereby mean 228 
differences for SB vs. PLA ranged from -16.8 s (-14.2%) to +61.2 s (+37.1%). In total, six out of eleven 229 
participants reported improvements in TTE2 performance above the 4.9% test-retest variability. Sub-230 
analysis for these six ‘responders’ revealed a significant increase of +31.2 s for TTE2 performance 231 
following SB compared to PLA (+21.1 %; p = 0.007; g = 1.65). Mean values and individual differences 232 
for TTE2 performance are displayed in Figure 4. 233 
 234 
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 236 
Estimated energy system contribution 237 
Mean ± SD values for energy demand (in L of O2) and contribution (kJ) from oxidative and glycolytic 238 
energetic systems are presented in Table 1. Excellent reproducibility was observed between SB and 239 
PLA trials for energy contribution from WAER (r = 0.96; p < 0.001) and W[LA] (r = 0.92; p < 0.001) 240 
during TTE1. Energy contribution from W[LA] was significantly increased during TTE2 for SB vs. PLA 241 
(p = 0.032) and displayed a moderate effect size (+6.84 kJ; CI: 0.7, 13.0; g = 0.69). In total, ten out of 242 
eleven participants reported greater W[LA] contribution following SB vs. PLA. No significant differences 243 
were observed for energy contribution from WAER during TTE2 (p > 0.05), although a small effect size 244 
was present for SB vs. PLA (+11.20 kJ; g = 0.48). 245 
 246 
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 248 
Perceived difficulty of exercise 249 
 
Participants achieved a similar level of volitional exhaustion during TTE1 for SB and PLA trials as 250 
good reproducibility was reported for peak RPE (r = 0.66; p = 0.049). No differences were observed 251 
between SB and PLA for peak RPE during TTE2 (p > 0.05). No significant differences were reported 252 
across treatments for PRE prior to TTE2 (p > 0.05), although a small effect size was present for SB vs. 253 
PLA (+0.36 units; g = 0.26).  254 
 255 
Perceptual responses to experimental beverages 256 
Four participants identified SB, six were unsure on treatments, whilst one incorrectly identified SB as 257 
PLA. Treatments were therefore considered successfully single-blinded and taste-matched (Fisher’s 258 
exact test, p = 1.000) and only a single participant directly suggested a poor taste.  259 
In total, ten out of eleven participants experienced some GI discomfort for the SB trial (timing 260 
and severity of peak symptom for each participant displayed in Table 2). Composite scores for GI 261 
discomfort revealed no symptoms at baseline, but symptom severity was mildly exacerbated for SB vs. 262 
PLA at 35 min recovery (Mdn: 11 mm vs. 10 mm) and post-TTE2 (Mdn: 11 mm vs. 9 mm). No 263 
significant treatment effects were present at any time point for AD or GF (p > 0.05). No significant 264 
treatment effects were observed at either 35 min recovery or post-TTE2 for flatulence, BUR and 265 
diarrhoea (all p > 0.05). Ratings of GI discomfort were significantly exacerbated for SB vs. PLA during 266 
the 24-h post-laboratory phase for flatulence (Mdn: 10 mm vs. 0 mm; Z = 2.366; p = 0.018), BUR (20 267 
mm vs. 0 mm; Z = 2.547; p = 0.011) and diarrhoea (17 mm vs. 0 mm; Z = 2.197; p = 0.028). Out of the 268 
five participants that failed to improve TTE2 performance for SB vs. PLA, only one directly reported 269 
an ergolytic effect of GI discomfort.  270 
 271 
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 273 
DISCUSSION 274 
This was the first study to investigate the effect of post-exercise NaHCO3 ingestion on blood pH and 275 
[HCO3-] recovery after 35 min and subsequent TTE running performance. No changes in acid-base 276 
balance status were reported for SB vs. PLA after the 35 min recovery period, however both [HCO3-] 277 
 
and [BLa-] were elevated post-TTE2. Post-exercise NaHCO3 ingestion did not significantly improve 278 
TTE2 performance, although a moderate effect size and a high degree of inter-individual variation was 279 
observed. Glycolytic energy system contribution was moderately increased during TTE2 for SB vs. 280 
PLA. Lastly, post-exercise NaHCO3 ingestion resulted in moderate-to-severe GI symptoms after TTE2 281 
and for the 24-h post-laboratory phase, therefore athletes should remain cautious when using this 282 
strategy to improve performance. 283 
The novel finding from this study was that NaHCO3 ingested after a fatiguing exercise bout 284 
failed to accelerate the recovery of blood pH, [HCO3-] and base excess to ‘neutral’ levels within 35 min 285 
when compared to PLA. These results contrast findings from pre-exercise ingestion studies suggesting 286 
that NaHCO3 accelerated the restoration of acid-base balance homeostasis within 30-40 min (Pruscino 287 
et al., 2008; Gough et al., 2019a). This discrepancy is most likely explained by the pre-exercise ingestion 288 
strategy previously employed, since this would have resulted in the enhanced buffering response being 289 
utilised during initial exercise (i.e., protecting against severe acid-base balance disturbances), in turn 290 
allowing for blood pH and [HCO3-] to recover to baseline status ‘faster’. Indeed, Gough et al. (2017b) 291 
reported that NaHCO3 administered following TTE cycling improved acid-base balance within 90 min 292 
compared to a placebo (blood pH, ~0.10 units; [HCO3-], ~7.0 mmol.l-1). Nonetheless, as the authors 293 
waited until ~30 min post-exercise to administer NaHCO3, it was observed that blood pH and [HCO3-] 294 
had already naturally returned close to baseline (~7.42; ~25.0 mmol.l-1), therefore their results may 295 
represent the widely regarded alkalotic effect of pre-exercise supplementation.  296 
Our findings complement those from Gough et al. (2019b) demonstrating that post-exercise 297 
NaHCO3 ingestion from a state of metabolic acidosis resulted in a greater [HCO3-] after 75 min recovery 298 
(+8.6 mmol.l-1). The relatively unchanged acid-base balance status at 35 min recovery herein can be 299 
attributed to a blunted extracellular buffering response since orally administered HCO3- had likely not 300 
been fully absorbed within the duodenum (Gough et al., 2017a). It is expected that substantial changes 301 
in enhanced HCO3- buffering only commenced during the second TTE protocol, which is demonstrated 302 
by the elevated [HCO3-] for post-TTE2 following SB, thus offering one possible explanation for the 303 
moderate effect size reported for TTE2 performance. These findings suggest however that the ingestion 304 
 
of NaHCO3 immediately post-exercise is not an effective strategy for accelerating the restoration of 305 
acid-base balance homeostasis when only a limited recovery period is available.  306 
The performance enhancing effects of NaHCO3 ingestion on TTE running were considerably 307 
blunted when compared to previous post-exercise NaHCO3 studies (Gough et al., 2017b; Gough et al., 308 
2019b), instead more closely representing the equivocal benefits reported during repeated bout exercise 309 
protocols (Zabala et al., 2011; Pruscino et al., 2008). The discrepancy between results is attributed to a 310 
dampened extracellular buffering response, whereby all participants ended the recovery period in a 311 
relatively ‘neutral’ acid-base balance status (i.e., opposed to a metabolic alkalosis from previous post-312 
exercise studies). Despite the continual rise in [HCO3-] during the warm-up prior to TTE2 that was 313 
demonstrated by our sub-set of data for 40 min recovery, it is unlikely that differences in [HCO3-] for 314 
SB vs. PLA consistently achieved the 5.0-6.0 mmol.l-1 minimal buffering threshold that has been 315 
theorised to maximise potential performance benefits (Carr et al., 2011). These changes in TTE2 316 
performance did however display a large degree of inter-individual variation, whereby a significant 317 
‘true’ effect of NaHCO3 was observed for the six participants (i.e., ‘responders’) that improved TTE2 318 
duration above the 4.9% within-subject CV for the TTE protocol. Considering that large variability in 319 
performance responses following NaHCO3 ingestion is common (Saunders et al., 2014), likely due to 320 
between participant differences in HCO3- absorption kinetics (Gough et al. 2017a), it is recommended 321 
that athletes first trial the supplement within training regimes, before then applying to a competitive 322 
‘real-world’ situation if positive results are obtained. Nonetheless, as three of these ‘responders’ 323 
identified SB (from a breaking of study blinding due to GI symptoms) and reported higher PRE (~2 324 
units) prior to TTE2, it is also possible that improvements were partially accounted to an ‘expectancy 325 
of ergogenicity’ following NaHCO3 ingestion (Higgins and Shaabir, 2016). Additional work should 326 
now investigate the inter-individual variation of performance enhancing effects following post-exercise 327 
NaHCO3 ingestion on more robust time-trial protocols that are less likely to be influenced by 328 
psychological bias.  329 
Post-exercise NaHCO3 ingestion elevated W[LA] energy contribution during subsequent 330 
exercise, which agrees with previous pre-exercise ingestion findings (Gurton et al., 2020; da Silva et 331 
al., 2019) and offers additional mechanistical insight to explain changes in TTE performance. Despite 332 
 
the limited recovery period, an acute NaHCO3 dose induced a sufficient change in alkalotic state to 333 
augment total glycolytic flux during TTE2, which was likely caused by up-regulated lactate-H+ co-334 
transport from intramuscular environments via the monocarboxylate transporter (Messonnier et al., 335 
2007). The elevated post-TTE2 [BLa-] indirectly demonstrates increased activation of the glycolytic 336 
energetic system following NaHCO3 ingestion, although the magnitude of increase was lower than from 337 
previous studies (Gough et al., 2017b; Gough et al., 2019b). One explanation for this discrepancy relates 338 
to the diminished extracellular buffering response as [HCO3-] was only ~3-4 mmol.l-1 higher at the start 339 
of TTE2 for SB vs. PLA, whereas Gough et al. (2017b) induced a substantial metabolic alkalosis prior 340 
to the second exercise bout ([HCO3-]: ~7 mmol.l-1 higher), resulting in a greater number of H+ that could 341 
be neutralised. Based on the 1:1 stoichiometry of the HCO3- and H+ reaction, and assuming that total 342 
blood volume was ~5 L,  then SB from this current study would have only neutralised an additional ~15 343 
mmol.l-1 of H+ compared to PLA (opposed to ~30 mmol.l-1 from Gough et al., 2017b), therefore 344 
providing justification for our dampened up-regulation of glycolytic contribution. It is important to note 345 
though, our results may partially reflect greater lactate efflux from muscles, instead of an increased 346 
glycolytic flux (da Silva et al., 2019). Considering that participants also reported small, unexpected 347 
increases for WAER during TTE2, which were partly attributed to the greater total work performed for 348 
SB vs. PLA (i.e., increased running distance), it is possible that we slightly overestimated the ‘true’ 349 
effect of NaHCO3 on energy system contribution. Future research should investigate whether NaHCO3 350 
ingested within recovery directly up-regulates glycolytic flux (i.e., from invasive muscle biopsies 351 
techniques) during subsequent controlled work-rate/duration exercise protocols.  352 
Moderate-to-severe GI symptoms following the dissociation of NaHCO3 within gastric acid 353 
have been widely documented (Cameron et al., 2010; Carr et al., 2011). Our results demonstrated mildly 354 
exacerbated GI discomfort for SB at 35 min recovery compared to baseline, which is in agreement to 355 
one post-exercise ingestion study (Gough et al., 2017b), but not the other (Gough et al., 2019b). These 356 
disparities might be attributed to differences in assessment protocols (i.e., visual analogue scales vs. 11-357 
point likert scales), or the established inter-individual variation for GI discomfort, whereby some 358 
athletes report greater gastric tolerability to NaHCO3 ingestion than others (Heibel et al., 2018). GI 359 
discomfort was moderately exacerbated for SB vs. PLA post-TTE2 (i.e., reflecting worse symptoms 360 
 
during exercise), however only a single participant suggested these side-effects impacted TTE2 361 
performance, therefore our results reaffirm that GI discomfort might not directly exhibit an ergolytic 362 
effect (Higgins et al., 2013; Gough et al., 2018). One novel finding was that post-exercise NaHCO3 363 
ingestion resulted in severe GI discomfort for the 24-h post-laboratory phase (i.e., n = 5, diarrhoea), in 364 
theory proving detrimental to athletes during future training and competition. Athletes suffering from 365 
severe GI discomfort could opt for delivery strategies that bypass gastric side-effects, such as 366 
administration via enteric-coated capsules which adequately reduce severity and occurrence of GI 367 
symptoms (Hilton et al., 2020a), whilst still eliciting a sufficient, albeit delayed metabolic alkalosis 368 
(>6.0 mmol.l-1; peak response, 90-110 min) that improves exercise performance (Hilton et al., 2020b). 369 
Additional work is required to elucidate the efficacy of enteric-coated NaHCO3 capsules when only a 370 
limited amount of time is available between exercise bouts. 371 
There are some methodological limitations in the present study. Firstly, a single-blind study 372 
design is considered sub-optimal for nutritional intervention research, however this was purely due to 373 
logistical reasons (i.e., lack of research staff). Additional control measures were put in place such as the 374 
standardisation of verbal encouragement during TTE protocols (e.g., “keep going” every 15 s) and the 375 
use of a supplement belief questionnaire (Gough et al., 2017a) that for the most part indicated we 376 
blinded NaHCO3 from participants. Another limitation was our inability to directly quantify glycolytic 377 
flux and contribution from the ATP-PCr energetic system. Due to the importance of measuring blood 378 
pH and [HCO3-] immediately post-exercise, we were unable to identify a clear excess-post oxygen 379 
consumption curve after TTE exercise, therefore ATP-PCr calculations were removed from analysis. 380 
Lastly, the 35 min recovery was potentially too short for post-exercise NaHCO3 ingestion to have a 381 
substantial effect on acid-base balance recovery, although previously published data (Gough et al., 382 
2017a) suggests that 0.3 g.kg-1 BM NaHCO3 increases [HCO3-] by ~5.0 mmol.l-1 within 40 min. This 383 
length of recovery was chosen as it best reflects the time required for blood pH and [HCO3-] to naturally 384 
return close to baseline (Gough et al., 2017b; Pruscino et al., 2008), which allowed us to investigate the 385 
effect of post-exercise NaHCO3 ingestion on the restoration of acid-base balance homeostasis and 386 




The ingestion of NaHCO3 immediately after an initial fatiguing exercise bout is not an effective strategy 390 
for accelerating the restoration of acid-base balance homeostasis (blood pH, HCO3-, base excess) when 391 
only a limited recovery period is present. This was attributed to a blunted extracellular buffering 392 
response, most likely as orally administered HCO3- had not been fully absorbed within the duodenum. 393 
Post-exercise NaHCO3 ingestion did not significantly improve TTE2 performance, although the 394 
moderate effect size and high degree of variability advocate that coaches and practitioners administer 395 
NaHCO3 on an individual basis. Small-to-moderate changes in TTE2 performance were likely due to 396 
enhanced HCO3- buffering and the up-regulation of glycolytic activation specifically during TTE2 397 
exercise. NaHCO3 ingestion resulted in severe post-exercise GI discomfort that may prove detrimental 398 
to athletes during subsequent training bouts or competition events. Future research should investigate 399 
the application of alternative NaHCO3 administration strategies (e.g., enteric-coated capsules) on the 400 
recovery of acid-base balance, GI discomfort and repeated bout exercise performance.    401 
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Figure 1 CONSORT 2010 reporting guidelines for research flowchart. 
 
Figure 2 Overview of study design and experimental procedures. Abbreviations: v-VO2max, maximal 
running velocity; SB, sodium bicarbonate; PLA, placebo; GI, gastrointestinal; BLa-, blood lactate; BG, 
blood gas; PRE, perceived readiness to exercise; TTE1/2, time-to-exhaustion protocol one/two.  
 
Figure 3 (A-D) Mean ± SD changes in acid-base balance status (A, blood bicarbonate; B, blood pH; C, 
base excess; D, blood lactate). Some error bars are removed for clarity. * denotes significantly higher 
for SB vs. PLA (p < 0.05). Dashed horizontal lines represent baseline/normal acid-base balance status. 
 
Figure 4 Mean differences and inter-individual variation (dashed lines between data points) for 
subsequent time-to-exhausting running protocols. 
 
